Henriette V. D. W.
- Country
- Sweden
- Department
- Department of Cardiology, Heart Center, 581 85 Linköping, Universitetssjukhuset i Linköpi
Research Overview
- Randomized Interventional Trial of Spironolactone and Eplerenone in Heart Failure with Preserved Ejection Fraction Patients
- Evaluation of Laroprovstat (AZD0780) on LDL-C Levels in Heterozygous Familial Hypercholesterolemia: A Phase III Randomized, Double-Blind, Placebo-Controlled Study
- TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Transthyretin-Mediated Amyloidosis with Cardiomyopathy (ATTR amyloidosis with cardiomyopathy)
Data & Insights
Has run more than one trial at 17 of 180 partner sites.
Specializations
Coronary artery disease and revascularization strategies
Henriette concentrates on the pathophysiology and therapeutic options for coronary artery disease, emphasizing both surgical and percutaneous approaches.
- Multi‑vessel coronary artery disease
- Left main coronary stenosis
- Coronary artery bypass grafting outcomes
Her work supports evidence‑based decisions for complex coronary anatomy and long‑term vessel patency.
Heart failure with preserved ejection fraction
She investigates clinical phenotypes and novel interventions targeting heart failure with preserved ejection fraction (HFpEF).
- Diastolic dysfunction assessment
- Pharmacologic modulation of myocardial relaxation
- Device‑based therapies for HFpEF
The focus is on improving functional capacity and reducing hospitalizations in this growing patient group.
Atrial fibrillation management
Henriette’s research addresses rhythm and rate control, as well as stroke prevention in patients with atrial fibrillation.
- Catheter ablation techniques
- Anticoagulation strategies in comorbid populations
- Risk stratification for recurrence
She integrates electrophysiological insights with personalized therapeutic pathways.
Cardiorenal interactions and acute kidney injury
Her investigations explore the bidirectional relationship between cardiac dysfunction and renal impairment, particularly acute kidney injury after cardiac surgery.
- Renal protection during coronary artery bypass grafting
- Biomarker‑guided early detection of AKI
- Therapeutic modulation of cardiorenal syndrome
These studies aim to reduce postoperative renal complications and improve overall cardiovascular outcomes.
Preventive cardiology and metabolic risk
Henriette is active in the prevention of atherosclerotic cardiovascular disease through management of metabolic risk factors.
- Hyperlipidemia and dyslipidemia treatment
- Obesity‑related cardiovascular risk
- Hypertension and diabetes control
Her work emphasizes lifestyle interventions and pharmacologic therapies to lower long‑term cardiovascular events.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.